3,4-methylenedioxyamphetamine has been researched along with fluorodeoxyglucose f18 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arning, C; Buell, U; Gouzoulis-Mayfrank, E; Kaiser, HJ; Sabri, O; Sass, H; Schreckenberger, M; Wagenknecht, G; Zeggel, T; Zimny, M | 1 |
1 trial(s) available for 3,4-methylenedioxyamphetamine and fluorodeoxyglucose f18
Article | Year |
---|---|
"Ecstasy"-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology. An 18-FDG PET study.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Cerebral Cortex; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Disorders; Middle Aged; Psychological Tests; Radionuclide Imaging; Radiopharmaceuticals | 1999 |